Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Adaptive Biotechnologies Corp (ADPT)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adaptive Biotechnologies Corp since year 2005.
Table 2 shows the detailed insider transactions of Adaptive Biotechnologies Corp since 2005.
The reporting company's ticker symbol is ADPT. The reporting company's CIK number is 1478320.
The total value of stock buying since 2005 is $15,244,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $6,600.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-10-23||Robins Chad M (CEO and Chairman)||Option Ex||20,000||.33||6,600|
|2019-07-01||Hill Nancy Louise (Sr Vice President, Operations)||Buy||11,200||20.00||224,000|
|2019-07-01||Shabet Rose Sharon||Buy||500,000||20.00||10,000,000|
|2019-07-01||Cohen Chad M (Chief Financial Officer)||Buy||1,000||20.00||20,000|
Insider trading activities including stock purchases, stock sales, and option exercises of ADPT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adaptive Biotechnologies Corp (symbol ADPT, CIK number 1478320) see the Securities and Exchange Commission (SEC) website.